(KYMR) Kymera Therapeutics - Performance -21.6% in 12m
Compare KYMR with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-19.26%
#44 in Group
Rel. Strength
38.80%
#4870 in Universe
Total Return 12m
-21.61%
#52 in Group
Total Return 5y
-9.59%
#40 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -10.93%
(?) Percentile in Group
12m Total Return: KYMR (-21.6%) vs XBI (-14.9%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| UTHR NASDAQ United Therapeutics |
7.21% | 14% | 161% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
| HLN NYSE Haleon |
7.98% | 32.4% | 49.3% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
| AMGN NASDAQ Amgen |
-7.04% | -11.2% | 27.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
| LONN SW Lonza |
11.7% | 13.3% | 33.5% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
| BIM PA Biomerieux |
2.2% | 21% | -1.63% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
| KMDA NASDAQ Kamada |
13.3% | 27.1% | -5.64% | 27.5 | 25.1 | 1 | 32.5% | 3.93% |
| NBIX NASDAQ Neurocrine Biosciences |
27.3% | -15% | 1.88% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
| ERF PA Eurofins Scientific SE |
20% | 0.38% | 8.05% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: KYMR vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for KYMR
| Total Return (including Dividends) | KYMR | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 24.67% | 2.77% | 5.69% |
| 3 Months | -12.61% | -14.21% | -6.49% |
| 12 Months | -21.61% | -14.88% | 9.72% |
| 5 Years | -9.59% | -26.47% | 107.51% |
| Trend Score (consistency of price movement) | KYMR | XBI | S&P 500 |
| 1 Month | 67.1% | 57% | 89.4% |
| 3 Months | -52.3% | -82.3% | -72% |
| 12 Months | -29.0% | -53.1% | 49.3% |
| 5 Years | -31.2% | -53.9% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #15 | 21.3% | 18.0% |
| 3 Month | #74 | 1.86% | -6.55% |
| 12 Month | #52 | -7.90% | -28.6% |
| 5 Years | #36 | 31.4% | -49.2% |
FAQs
Does KYMR Kymera Therapeutics outperforms the market?
No,
over the last 12 months KYMR made -21.61%, while its related Sector, the SPDR S&P Biotech (XBI) made -14.88%.
Over the last 3 months KYMR made -12.61%, while XBI made -14.21%.
Over the last 3 months KYMR made -12.61%, while XBI made -14.21%.
Performance Comparison KYMR vs Indeces and Sectors
KYMR vs. Indices KYMR is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -10.6% | 19.0% | -36.8% | -31.3% |
| US NASDAQ 100 | QQQ | -10.9% | 17.3% | -37.3% | -32.4% |
| US Dow Jones Industrial 30 | DIA | -10.5% | 22.0% | -35.8% | -27.9% |
| German DAX 40 | DAX | -11.1% | 9.61% | -62.4% | -46.4% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -10.8% | 21.8% | -36.1% | -27.9% |
| Hongkong Hang Seng | HSI | -13.5% | 9.77% | -46.3% | -29.8% |
| India NIFTY 50 | INDA | -6.90% | 21.5% | -38.7% | -23.6% |
| Brasil Bovespa | EWZ | -13.6% | 13.1% | -46.1% | -15.3% |
KYMR vs. Sectors KYMR is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -9.97% | 18.2% | -43.0% | -42.0% |
| Consumer Discretionary | XLY | -12.0% | 18.0% | -34.7% | -36.4% |
| Consumer Staples | XLP | -9.74% | 24.0% | -43.8% | -28.9% |
| Energy | XLE | -12.9% | 20.2% | -30.8% | -12.6% |
| Financial | XLF | -11.3% | 17.8% | -42.7% | -43.2% |
| Health Care | XLV | -6.50% | 27.7% | -31.6% | -15.6% |
| Industrial | XLI | -11.5% | 16.4% | -37.8% | -32.0% |
| Materials | XLB | -10.8% | 19.6% | -32.8% | -15.5% |
| Real Estate | XLRE | -9.81% | 17.8% | -39.2% | -35.2% |
| Technology | XLK | -11.4% | 15.0% | -34.6% | -27.7% |
| Utilities | XLU | -11.3% | 19.5% | -44.6% | -37.6% |
| Aerospace & Defense | XAR | -10.8% | 15.5% | -46.1% | -47.6% |
| Biotech | XBI | -2.88% | 21.9% | -15.8% | -6.73% |
| Homebuilder | XHB | -10.2% | 19.1% | -23.2% | -12.7% |
| Retail | XRT | -10.7% | 18.5% | -30.6% | -15.4% |